Efficiency of transformation of lymphocytes by Epstein-Barr virus - PubMed (original) (raw)

Efficiency of transformation of lymphocytes by Epstein-Barr virus

E Henderson et al. Virology. 1977 Jan.

No abstract available

PubMed Disclaimer

Similar articles

• Suppressor cells in experimentally trypanosomiasis.
  Jayawardena AN, Waksman BH. Jayawardena AN, et al. Nature. 1977 Feb 10;265(5594):539-41. doi: 10.1038/265539a0. Nature. 1977. PMID: 299925 No abstract available.
• Mitogenic response of marmoset lymphocytes: cytokinetics and identification of responsive cells.
  Kateley JR, Nickerson DA, Gengozian N. Kateley JR, et al. Immunology. 1977 Nov;33(5):653-662. Immunology. 1977. PMID: 145405 Free PMC article.
• Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus.
  Robinson J, Frank A, Henderson E, Schweitzer J, Miller G. Robinson J, et al. Infect Immun. 1979 Oct;26(1):225-31. doi: 10.1128/iai.26.1.225-231.1979. Infect Immun. 1979. PMID: 227794 Free PMC article.
• Some aspects of the biologic behavior of Epstein-Barr virus.
  Miller G. Miller G. Adv Pathobiol. 1976;(5):25-41. Adv Pathobiol. 1976. PMID: 220856 No abstract available.
• Immunologic considerations in the selection of nonhuman primate models for studies of Epstein--Barr virus-associated diseases in man.
  Levine PH, Wallen WC, Lai PK, Jerrells TR, Fuccillo DA. Levine PH, et al. Comp Immunol Microbiol Infect Dis. 1979;2(2-3):243-56. doi: 10.1016/0147-9571(79)90012-2. Comp Immunol Microbiol Infect Dis. 1979. PMID: 228898 Review. No abstract available.

Cited by

• Momordica anti-HIV protein MAP30 abrogates the Epstein-Barr virus nuclear antigen 1 dependent functions in host cells.
  Huang WH, Su WM, Wang CW, Fang YH, Jian YW, Hsu HJ, Peng CW. Huang WH, et al. Heliyon. 2023 Oct 30;9(11):e21486. doi: 10.1016/j.heliyon.2023.e21486. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027600 Free PMC article.
• Methionine metabolism controls the B cell EBV epigenome and viral latency.
  Guo R, Liang JH, Zhang Y, Lutchenkov M, Li Z, Wang Y, Trujillo-Alonso V, Puri R, Giulino-Roth L, Gewurz BE. Guo R, et al. Cell Metab. 2022 Sep 6;34(9):1280-1297.e9. doi: 10.1016/j.cmet.2022.08.008. Cell Metab. 2022. PMID: 36070681 Free PMC article.
• Nanotechnology Frontiers in γ-Herpesviruses Treatments.
  Granato M. Granato M. Int J Mol Sci. 2021 Oct 22;22(21):11407. doi: 10.3390/ijms222111407. Int J Mol Sci. 2021. PMID: 34768838 Free PMC article. Review.
• Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells.
  Martínez LE, Daniels-Wells TR, Guo Y, Magpantay LI, Candelaria PV, Penichet ML, Martínez-Maza O, Epeldegui M. Martínez LE, et al. Mol Cancer Ther. 2021 Sep;20(9):1592-1602. doi: 10.1158/1535-7163.MCT-21-0074. Epub 2021 Jun 22. Mol Cancer Ther. 2021. PMID: 34158342 Free PMC article.
• Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.
  Wang LW, Shen H, Nobre L, Ersing I, Paulo JA, Trudeau S, Wang Z, Smith NA, Ma Y, Reinstadler B, Nomburg J, Sommermann T, Cahir-McFarland E, Gygi SP, Mootha VK, Weekes MP, Gewurz BE. Wang LW, et al. Cell Metab. 2019 Sep 3;30(3):539-555.e11. doi: 10.1016/j.cmet.2019.06.003. Epub 2019 Jun 27. Cell Metab. 2019. PMID: 31257153 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations